{"podcast":{"title":"Answers from the Lab","slug":"answers-from-the-lab-870296","podcast_index_feed_id":870296,"rss_url":"https://feeds.transistor.fm/answers-from-the-lab","website_url":"https://news.mayocliniclabs.com/podcast/answers-from-the-lab/","image_url":"https://img.transistorcdn.com/B9HbHcxSMFuy8GSjzQspBU_yr7OZ0kDg-c2slusbf14/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjNj/ZDc0NTE0MWNlOWRl/YzRiN2Q3NDg2Mjg5/YWE4MS5qcGc.jpg","author":"Mayo Clinic Laboratories","episode_count":383,"summary":"A Mayo Clinic curated podcast sharing Mayo Clinic knowledge and advancements on the state of testing, science, and people who are making it happen behind the scenes.","last_synced_at":"2026-06-11T16:18:30.710370+00:00","page_url":"https://stenobird.com/podcast/answers-from-the-lab-870296"},"episode":{"title":"Unlocking the Unknown With Metagenomics","slug":"unlocking-the-unknown-with-metagenomics","published_at":"2025-11-20T19:00:00+00:00","page_url":"https://stenobird.com/podcast/answers-from-the-lab-870296/unlocking-the-unknown-with-metagenomics","show_page_url":"https://stenobird.com/podcast/answers-from-the-lab-870296","url":"https://share.transistor.fm/s/0dff0eb0","audio_url":"https://media.transistor.fm/0dff0eb0/18b48169.mp3","summary":"In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D. , president and CEO of Mayo Clinic Laboratories, to discuss recent news about Protecting Access to Medicare Act (PAMA) reform. Then, Dr. Pritt welcomes Trish Simner, Ph.D., a clinical microbiologist at Mayo Clinic, for an in-depth conversation about metagenomics. PAMA reform update and new RESULTS Act (00:30): Hear about options under consideration for PAMA reform, including the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. When cerebrospinal fluid (CSF) metagenomics benefit patient care (06:04) : Explore how CSF metagenomics work and when it is appropriate to use this advanced diagnostic tool in clinical practice. Advancement and innovation in metagenomics (18:15) : Discover how recent and upcoming innovation is expanding metagenomic testing capabilities. Note: Information in this post was accurate at the time of its posting. Resources Answers From the Lab podcast: Developments for LDT Regulation and Laboratory Reimbursement: Bill Morice, M.D., Ph.D. Metagenomics: Identifying elusive pathogenic microorganisms","meta_description":"In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Mor…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1587,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/answers-from-the-lab-870296/episodes/unlocking-the-unknown-with-metagenomics/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/answers-from-the-lab-870296/unlocking-the-unknown-with-metagenomics.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}